The A-share chemical pharmaceutical sector fluctuated upward, with Hendi Pharmaceutical rising by more than 10%, Xinhua Pharmaceutical hitting the daily limit, and Jinshi Asia Pharmaceutical, Haichuang Pharmaceutical, and Doray Pharmaceuticals following suit.